Andrew Saxon

Andrew Saxon serves as Chief Emeritus, Clinical Immunology/Allergy in the Department of Medicine, David Geffen School of Medicine at UCLA. He received his Medical degree from Harvard Medical School and is board certified in Internal Medicine, Allergy and Clinical Immunology and Diagnostic/Laboratory Immunology. Dr. Saxon is a world-renowned expert in human cellular and molecular immunology and serves as the Editor-in-Chief of Clinical Immunology, the official journal of the Clinical Immunology Society. Dr. Saxon is also a Professor of David Geffen School of Medicine at UCLA, where he and his colleagues were the first to recognize HIV/AIDS in 1980. They brought this new disease to the attention of the CDC in 1981 and published their seminal research describing it in the New England Journal of Medicine that same year. Dr. Saxon and his collaborators have made breakthrough immunology discoveries, particularly with respect to allergic antibodies (IgE), and conducted pioneering research into the role of environmental factors in the modulation of the human immune response. Dr. Saxon also has developed extensive experience with KLH (Keyhole limpet hemocyanin) in its various molecular forms in his work. He serves as the Chair of the Scientific Advisory Board at Stellar Biotechnologies, Inc. and has authored over 180 peer-reviewed research publications primarily dealing with the control and assessment of the human immune response.